Organogenesis Holding (ORGO) Misses Q2 EPS by 42c

Organogenesis Holding (NASDAQ: ORGO) reported Q2 EPS of ($0.77), $0.42 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $42.8 million versus the consensus estimate of $54.25 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• Zenas BioPharma (ZBIO) files for up to 7M share offering by selling stockholders